Kadowaki, T., Inagaki, N., Kondo, K., Nishimura, K., Kaneko, G., Maruyama, N., . . . Gouda, M. (2017). Efficacy and safety of canagliflozin as add‐on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24‐week, randomized, double‐blind, placebo‐controlled trial. Diabetes Obes Metab.
Style de citation ChicagoKadowaki, Takashi, et al. "Efficacy and Safety of Canagliflozin As Add‐on Therapy to Teneligliptin in Japanese Patients With Type 2 Diabetes Mellitus: Results of a 24‐week, Randomized, Double‐blind, Placebo‐controlled Trial." Diabetes Obes Metab 2017.
Style de citation MLAKadowaki, Takashi, et al. "Efficacy and Safety of Canagliflozin As Add‐on Therapy to Teneligliptin in Japanese Patients With Type 2 Diabetes Mellitus: Results of a 24‐week, Randomized, Double‐blind, Placebo‐controlled Trial." Diabetes Obes Metab 2017.